Hutch News

Hutch News

Stories tagged 'HIV superinfection'

25 powerful years of HIV research

Longstanding Mombasa Cohort helps answer questions about HIV risk and transmission

Feb. 26, 2018 | By Sabrina Richards / Fred Hutch News Service

For 25 years, Fred Hutch virologist Dr. Julie Overbaugh has helped lead the Mombasa Cohort, a unique group of women at high risk for HIV transmission.

View story >


Good News at Fred Hutch

Dr. Rainer Storb receives $12.9M to study blood stem-cell therapies for immune deficiencies; Dr. Julie Overbaugh studies HIV 'superinfection' to provide clues for better vaccine design

July 9, 2015 | By Fred Hutch staff

Dr. Rainier Storb receives $12.9M to study stem-cell therapies for immune deficiencies; Dr. Julie Overbaugh studies HIV 'superinfection' to provide clues for better vaccine design

View story >


HIV 'superinfection' boosts immune response

Overbaugh, Cortez-led study shows women infected by two different HIV strains exhibit strong antibody response; findings may aid vaccine development

April 2, 2012 | By Kristen Woodward

Researchers at the Fred Hutchinson Cancer Research Center found that women who have been infected by two different strains of HIV from two different sexual partners-a condition known as HIV superinfection-have more potent antibody responses that block the replication of the virus compared to women who've only been infected once.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.